A shadow economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Treatment Acquiring Traction Online
Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are urged to contact these profiles directly for source information, while also obtaining discount codes.
Thriving Commerce on Social Networks
Additionally, a flourishing market exists on Telegram, where communities with thousands of members share “before and after” images, administration instructions and assertions of rapid British shipping. Vendors promote the drug there before redirecting buyers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Experts Express Concerns
However, physicians and chemists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting substances of uncertain source.
Several experts stated the popularity for retatrutide could be connected to the rising price of approved slimming products such as Mounjaro.
Regulatory Status and Implementation
Marketing retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for human use under the British medical regulations.
Some content creators try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach medicines, marketing, and customer regulations, potentially leading to penalties, prosecution or imprisonment.
Platform Response and Content Elimination
According to TikTok, the platform has removed problematic content and prohibited related hashtags and search suggestions. The organization said it was dedicated to keeping the service secure and allocating resources in enhancing enforcement strategies.
Online Marketplace Activities
Research also discovered groups with up to 9,000 participants selling the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, populated with images of slimming results, positive reviews and step-by-step guides for mixing or injecting at home.
Within moments of entering one community, a seller shared WhatsApp details, where the majority of purchases occur. The seller provided an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about body mass, medical conditions or previous experience.
Item Information and Pricing
Inside these groups, messages display dark colored packages with Royal Mail labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20mg. When asked how much time a injector should last, sellers give conflicting answers ranging from a several days to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for Telegram said it regularly monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting materials they can’t verify. Even if the research behind this drug is valid, these digital versions may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to social media. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.
Her staff has previously encountered patients harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”
Producer Position
A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational substance not yet authorized … may subject users to potentially serious medical dangers”.